Genmab’s chief executive officer has actually consistently highlighted cancer cells medicine prospect acasunlimab as a significant sales intend to load the profits void at the end of the years. Currently, the firm is deserting its growth.
发布者:BY Maria Outze,转转请注明出处:https://robotalks.cn/genmab-drops-development-of-important-cancer-candidate/